SCHEMBL22868036

SCHEMBL22868036

COc1ccc(Oc2cnccc2C#N)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.61
GAA P10253 1/20 0.61
PTGS1 P23219 2/20 0.50
PTGS2 P35354 2/20 0.50
FNTA P49354 1/20 0.50
FNTB P49356 1/20 0.50
PGGT1B P53609 1/20 0.50
CYP19A1 P11511 4/20 0.49
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
AR P10275 2/20 0.45
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
CLK1 P49759 2/20 0.41
CLK2 P49760 2/20 0.41
CLK3 P49761 2/20 0.41
CDK5 Q00535 2/20 0.41
DYRK1A Q13627 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1024738 0.83 CLK1 (0.44) POLBGAACYP19A1ALDH1A1SMN1; SMN2
SCHEMBL29530507 0.83 CLK1 (0.44) POLBGAACYP19A1ALDH1A1SMN1; SMN2
SCHEMBL19243792 0.79 SLC22A12 (0.50) PTGS2ALDH1A1SMN1; SMN2ARCLK1
SCHEMBL5878576 0.77 CYP19A1 (0.49) POLBGAACYP19A1ALDH1A1SMN1; SMN2
SCHEMBL22169508 0.76 POLB (1.00) POLBGAAALDH1A1ARNPC1
SCHEMBL27151271 0.75 POLB (0.68) POLBGAAFNTAFNTBPGGT1B
SCHEMBL26317308 0.75 ALDH1A1 (0.42) POLBCYP19A1ALDH1A1SMN1; SMN2CA12
SCHEMBL4766762 0.75 APP (0.45) POLBGAACYP19A1ALDH1A1SMN1; SMN2
SCHEMBL5792344 0.75 SLC6A4 (0.58) POLBCYP19A1ALDH1A1SMN1; SMN2AR
SCHEMBL9853810 0.75 PTGS1 (0.54) PTGS1PTGS2ALDH1A1SMN1; SMN2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021003295-A1 MODULATORS OF HSD17B13 AND METHODS OF USE THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2021-01-07 WO disclosed